Medibank share price halted after hackers claim to have taken customer data

Medibank shares have been halted after hackers made contact…

| More on:
a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank shares have been halted on Wednesday
  • This follows news that hackers claim to have taken customer data from the private health insurance giant
  • Medibank previously stated that it didn't believe customer data was removed from its systems

The Medibank Private Ltd (ASX: MPL) share price will be one to watch carefully in the coming days.

This follows the release of an update on its cybersecurity incident after the market close today.

Why is the Medibank share price on watch?

Last week, Medibank revealed that it detected unusual activity on its network.

After taking immediate steps to contain the incident and engage specialised cyber security firms, the company stated that it didn't believe any customer data had been removed.

The company then went on to say that as a health company providing health insurance and health services, it holds a range of necessary personal information of customers. In light of this, it stressed that the protection of customers' data security is its highest priority.

Unfortunately, it may have failed with its highest priority, with the company no longer sure that customer data wasn't removed from its systems.

What's happened?

This afternoon, management revealed that it has received messages from a group that wishes to negotiate with the company regarding their alleged removal of customer data.

Medibank is treating the matter seriously and working urgently to establish if the claim is true.

As a result, the company has suspended its shares and they will remain that way until the matter is resolved.

Medibank's CEO, David Koczkar, commented:

I apologise and understand this latest distressing update will concern our customers. We have always said that we will prioritise responding to this matter as transparently as possible. "Our team has been working around the clock since we first discovered the unusual activity on our systems, and we will not stop doing that now. We will continue to take decisive action to protect Medibank customers, our people and other stakeholders.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »